bd 1047 has been researched along with sk&f-38393 in 1 studies
Studies (bd 1047) | Trials (bd 1047) | Recent Studies (post-2010) (bd 1047) | Studies (sk&f-38393) | Trials (sk&f-38393) | Recent Studies (post-2010) (sk&f-38393) |
---|---|---|---|---|---|
118 | 0 | 54 | 2,012 | 29 | 242 |
Protein | Taxonomy | bd 1047 (IC50) | sk&f-38393 (IC50) |
---|---|---|---|
Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 2.8 | |
D | Rattus norvegicus (Norway rat) | 0.19 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guo, L; Li, L; Wu, Z; Xu, Z; Zhen, X; Zheng, LT | 1 |
1 other study(ies) available for bd 1047 and sk&f-38393
Article | Year |
---|---|
Allosteric modulation of sigma-1 receptors by SKF83959 inhibits microglia-mediated inflammation.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Allosteric Regulation; Animals; Anti-Inflammatory Agents; Cell Line; Culture Media, Conditioned; Dehydroepiandrosterone; Enzyme Induction; Ethylenediamines; Interleukin-10; Ketoconazole; Lipopolysaccharides; Male; Mice; Microglia; Narcotic Antagonists; Neuroblastoma; Neuroimmunomodulation; Nitric Oxide; Nitric Oxide Synthase Type II; Piperazines; Protein Binding; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, sigma; Sigma-1 Receptor; Tumor Necrosis Factor-alpha | 2015 |